• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱上皮特异性重组腺病毒的构建及其对膀胱癌细胞的抑制作用。

Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell.

作者信息

He Xiang-Dong, Wang Zhi-Ping, Wei Hai-Yan, Zhou Qin, Wang De-Gui, Tian Jun-Qiang, Fu Sheng-Jun, Rodriguez Ronald

机构信息

Institute of Urology, Second Hospital of Lanzhou University, Lanzhou, PR China.

出版信息

Urol Int. 2009;82(2):209-13. doi: 10.1159/000200802. Epub 2009 Mar 19.

DOI:10.1159/000200802
PMID:19322012
Abstract

AIM

To construct urothelium-specific recombinant adenovirus and investigate its inhibition in bladder cancer cell.

METHODS

RT-PCR analysis was used to determine expression patterns of hUPII and coxsackie adenovirus receptor on multiple cell lines. Transient transfection and luciferase detecting assay were used to detect tissue specificity of the hUPII promoter. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed. Restrictive enzyme digestion assay and PCR confirmed the correct construction. The adenovirus E1A protein expressed in BIU-87 was tested by Western blot after cells were infected with recombinant adenovirus. Recombinant adenovirus Ad-UPII-E1A was tested for its inhibition in bladder cancer cell line BIU-87.

RESULTS

HUPII and CAR were expressed and the hUPII promoter is highly active in bladder cancer cell line BIU-87. Using homologous recombination in bacteria technology, the hUPII promoter and E1A gene were inserted into the genome of type 5 recombinant adenovirus. The E1A protein was markedly positive in the samples of BIU-87 cells infected with recombinant adenovirus Ad-UPII-E1A. MTT assay demonstrated recombinant adenovirus Ad-UPII-E1A inhibited bladder cancer cell BIU-87 growth.

CONCLUSION

The hUPII promoter shows high tissue specificity. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed and confirmed. Recombinant adenovirus Ad-UPII-E1A is effective in inhibition in bladder cancer cell line BIU-87.

摘要

目的

构建尿路上皮特异性重组腺病毒并研究其对膀胱癌细胞的抑制作用。

方法

采用逆转录-聚合酶链反应(RT-PCR)分析多种细胞系中hUPII和柯萨奇腺病毒受体的表达模式。利用瞬时转染和荧光素酶检测试验检测hUPII启动子的组织特异性。构建重组腺病毒Ad-UPII-E1A和Ad-UPII-Null。通过限制性酶切分析和聚合酶链反应(PCR)确认构建正确。用重组腺病毒感染细胞后,通过蛋白质免疫印迹法检测BIU-87中表达的腺病毒E1A蛋白。检测重组腺病毒Ad-UPII-E1A对膀胱癌细胞系BIU-87的抑制作用。

结果

hUPII和柯萨奇腺病毒受体(CAR)在膀胱癌细胞系BIU-87中表达,且hUPII启动子具有高活性。利用细菌中的同源重组技术,将hUPII启动子和E1A基因插入5型重组腺病毒基因组。在感染重组腺病毒Ad-UPII-E1A的BIU-87细胞样本中,E1A蛋白呈明显阳性。噻唑蓝(MTT)比色法表明重组腺病毒Ad-UPII-E1A抑制膀胱癌细胞BIU-87生长。

结论

hUPII启动子具有高组织特异性。构建并确认了重组腺病毒Ad-UPII-E1A和Ad-UPII-Null。重组腺病毒Ad-UPII-E1A对膀胱癌细胞系BIU-87具有有效抑制作用。

相似文献

1
Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell.膀胱上皮特异性重组腺病毒的构建及其对膀胱癌细胞的抑制作用。
Urol Int. 2009;82(2):209-13. doi: 10.1159/000200802. Epub 2009 Mar 19.
2
Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.膀胱癌特异性溶瘤腺病毒基因治疗与顺铂联合用于体外膀胱癌治疗
Tumour Biol. 2014 Nov;35(11):10879-90. doi: 10.1007/s13277-014-2353-7. Epub 2014 Aug 2.
3
Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.膀胱癌特异性重组溶瘤腺病毒在裸鼠皮下异种移植肿瘤模型中的分布与安全性评估。
Curr Gene Ther. 2012 Apr 1;12(2):67-76. doi: 10.2174/156652312800099599.
4
Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.携带 E1A-雄激素受体的膀胱癌特异性腺病毒在膀胱癌中的抗肿瘤作用。
Gene Ther. 2012 Nov;19(11):1065-74. doi: 10.1038/gt.2011.180. Epub 2012 Jan 5.
5
Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.人尿路上皮蛋白II启动子的克隆、分析及其在膀胱癌基因治疗中的应用
Cancer Gene Ther. 2004 Apr;11(4):263-72. doi: 10.1038/sj.cgt.7700672.
6
Effect of combined treatment of radiation and tissue-specific recombinant oncolytic adenovirus on bladder cancer cells.放疗与组织特异性重组溶瘤腺病毒联合治疗对膀胱癌细胞的影响。
Int J Radiat Biol. 2017 Feb;93(2):174-183. doi: 10.1080/09553002.2017.1231942. Epub 2016 Oct 14.
7
Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.人尿路上皮蛋白II启动子的鉴定及其在构建CG8840中的应用,CG8840是一种尿路上皮特异性腺病毒变体,与多西他赛联合使用可消除已形成的膀胱肿瘤。
Cancer Res. 2002 Jul 1;62(13):3743-50.
8
[Effect of mouse uroplakin II promoter on human bladder cancer cell line].[小鼠尿路上皮蛋白II启动子对人膀胱癌细胞系的作用]
Zhonghua Zhong Liu Za Zhi. 2004 Jan;26(1):22-5.
9
A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.一种通过CD46靶向的新型膀胱癌特异性溶瘤腺病毒及其与顺铂联合对CAR阴性表达癌细胞的作用。
Virol J. 2017 Aug 8;14(1):149. doi: 10.1186/s12985-017-0818-1.
10
Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.纤维修饰的腺病毒介导的自杀基因疗法能够在体外和体内有效消除膀胱癌细胞。
Oncotarget. 2016 Nov 1;7(44):71710-71717. doi: 10.18632/oncotarget.12324.

引用本文的文献

1
rAAV9-UPII-TK-EGFP can precisely transduce a suicide gene and inhibit the growth of bladder tumors.rAAV9-UPII-TK-EGFP 可以精确转导自杀基因并抑制膀胱肿瘤的生长。
Cancer Biol Ther. 2020 Dec 1;21(12):1171-1178. doi: 10.1080/15384047.2020.1844115. Epub 2020 Nov 20.
2
A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.一种通过CD46靶向的新型膀胱癌特异性溶瘤腺病毒及其与顺铂联合对CAR阴性表达癌细胞的作用。
Virol J. 2017 Aug 8;14(1):149. doi: 10.1186/s12985-017-0818-1.
3
Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.
纤维修饰的腺病毒介导的自杀基因疗法能够在体外和体内有效消除膀胱癌细胞。
Oncotarget. 2016 Nov 1;7(44):71710-71717. doi: 10.18632/oncotarget.12324.
4
Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy.腺病毒介导的泛素连接酶RNF8下调使膀胱癌对放疗敏感。
Oncotarget. 2016 Feb 23;7(8):8956-67. doi: 10.18632/oncotarget.6909.
5
Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.膀胱癌特异性重组溶瘤腺病毒在裸鼠皮下异种移植肿瘤模型中的分布与安全性评估。
Curr Gene Ther. 2012 Apr 1;12(2):67-76. doi: 10.2174/156652312800099599.
6
Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.携带 E1A-雄激素受体的膀胱癌特异性腺病毒在膀胱癌中的抗肿瘤作用。
Gene Ther. 2012 Nov;19(11):1065-74. doi: 10.1038/gt.2011.180. Epub 2012 Jan 5.
7
Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers.纤维修饰的携带 TRAIL 的腺病毒载体增强了对膀胱癌的抗肿瘤能力。
Mol Cell Biochem. 2011 Jul;353(1-2):93-9. doi: 10.1007/s11010-011-0778-5. Epub 2011 Mar 25.